Sentinel node biopsy in cutaneous melanoma

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 40, Issue 1, 2006, Pages 24-31

  Lock Andersen, Jørgen ^a   Horn, Janne ^a   Sjøstrand, Helle ^a   Nürnberg, Birgit Meinecke ^a   Stokholm, Knud Heine ^a  

^a ROSKILDE HOSPITAL   (Denmark)

Author keywords

Melanoma; Prognosis; Recurrence; Sentinel lymph node biopsy; Staging

Indexed keywords

TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREOPERATIVE EVALUATION; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 31544454761     PISSN: 02844311     EISSN: 11013923     Source Type: Journal    
DOI: 10.1080/02844310500370282     Document Type: Article

References (24)

1. Lock-Andersen J, Partoft S, Jensen MG. Patterns of the first lymph node metastases in patients with cutaneous malignant melanoma of axial localization. Cancer 1988;62:2073-7.
2. Reintgen D, Cruse W, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;6:759-67.
3. Balch CM, Soong S, Gerschenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.
4. Lock-Andersen J, Rossing N, Drzewiecki KT. Preoperative cutaneous lymphoscintigraphy in malignant melanoma. Cancer 1989;63:77-82.
5. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - a multicenter trial. Ann Surg 1999;230:453-65.
6. Morton DL, Wen D, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
7. Thompson JF, Niewind P, Uren RF, et al. Single-dose isotope injection for both preoperative lymphoscintigraphy and intra-operative identification in melanoma patients. Melanoma Res 1997;7:500-6.
8. Balch CM, Buzaid AC, Soong S, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48.
9. 0. The Danish Melanoma Group 2003. www.melanoma.dk
10. DMG 2003 Kirurgisk Protokol - Kirurgisk behandling af patienter med kutant malignt melanom. The Danish Melanoma Group 2003. www.melanoma.dk
11. DMG 2003 Klinik og patologi - Registrering af kliniske data og patologi data hos patienter med kutant malignt melanom. The Danish Melanoma Group 2003. www.melanoma.dk
12. Morton DL. Lymphatic mapping and sentinel node lymphadenectomy for melanoma: past, present and future. Ann Surg Oncol 2001;8(suppl 9):22S-8S.
13. Gad D, Sjøgren P. Sentinel node diagnostik hos patienter med kutant malignt melanom. Ugeskr Laeger 2003;165:2567-70.
14. Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR. Sentinel node biopsy for melanoma: a study of 241 patients. Melanoma Res 2004;14:521-6.
15. Lowe JB, Hurst E, Moley JF, Cornelius LA. Sentinel lymph node biopsy in patients with thin melanoma. Arch Dermatol 2003;139:617-21.
16. Caracò C, Celentano E, Lastoria S, et al. Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimetres. Ann Surg 2004;11:198S-203S.
17. Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥ 4 mm) primary melanoma. Ann Surg Oncol 2000;7:160-5.
18. Topping A, Dewar D, Rose V, et al. Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience. Br J Plast Surg 2004;57:97-104.
19. Fincher TR, McCarty TM, Fisher TL, et al. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg 2003;186:675-81.
20. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative lymph node biopsy in 234 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
21. Hettiaratchy SP, Kang N, O'Toole G, et al. Sentinel node biopsy in malignant melanoma: a series of 100 consecutive patients. Br J Plast Surg 2000;53:559-62.
22. Wrone DA, Tanabe KK, Cosimi B, et al. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma. Arch Dermatol 2000;136:511-4.
23. Woltsche-Kahr I, Komericki P, Kränke B, et al. Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. Eur J Surg Oncol 2000;26:313-4.
24. McMasters KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001;8(suppl 9):41S-3S.